Insider Trading Reports for Facebook, Microsoft, Gilead Sciences, Bank of America, Riverbed, and Wells Fargo



US market investors can reveal the performance of company insiders from the insider trading reports. Today’s reports will cover the following stocks: Facebook (NASDAQ:FB), Microsoft (NASDAQ:MSFT), Gilead Sciences (NASDAQ:GILD), Bank of America (NYSE:BAC), Riverbed (NASDAQ:RVBD), and Wells Fargo (NYSE:WFC).
 
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
 
Report Highlights:
 
Facebook Inc (NASDAQ:FB): By the end of last trading session, the shares of Facebook (NASDAQ:FB) lost 0.06% (or US$0.03) to US$47.53 with 70.73 million shares exchanged hands, compared to daily average volume of 87.36 million. Insiderslab.com found company VP Marketing & Bus. Part., David B. Fischer, sold his shares at the price of US$49.28 on November 7. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for FB here.
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/FB/Facebook.pdf
 
Microsoft Corporation (NASDAQ:MSFT): By the end of last trading session, Microsoft (NASDAQ:MSFT) shares earned 0.75% to US$37.78 with about 36.74 million shares exchanged hands for the session, compared to its average volume of 43.71 million shares. Insiderslab.com found company Executive Vice President, Bradford L. Smith, sold his shares at the price of US$37.97 for about US$7.59 million on November 6. Investors may want to find out how Microsoft insiders like CEOs, CFOs and Directors are thinking about the future of the company.
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/MSFT/Microsoft.pdf
 
Gilead Sciences, Inc. (NASDAQ:GILD): By the end of last trading session, Gilead Sciences (NASDAQ:GILD) shares regained 2.65% to US$67.37 with about 12.51 million shares exchanged hands for the session, compared to its average volume of 9.65 million shares. Insiderslab.com found company CFO, Robin L. Washington, sold his shares at the price of US$68.63 on October 6. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Gilead Sciences are starting to sell more company shares. See insider trade report for GILD here.
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/GILD/GileadSciences.pdf
 
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
 
Bank of America Corp (NYSE:BAC):
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/BAC/BankofAmerica.pdf
 
Riverbed Technology, Inc. (NASDAQ:RVBD):
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/RVBD/Riverbed.pdf
 
Wells Fargo & Co (NYSE:WFC):
 
Read Full Report: http://www.insiderslab.com/PR3/111113A/WFC/WellsFargo.pdf
 
Combine insider trading signals with consensus earnings forecast report will give better equity research result.  Check out the latest earning forecast reports of Bank of America (NYSE:BAC), Riverbed (NASDAQ:RVBD), Barrick Gold (NYSE:ABX), NVIDIA (NASDAQ:NVDA), Vale SA (NYSE:VALE), and JPMorgan Chase (NYSE:JPM) for FREE:
http://www.earningforecast.com/News/1393/
 
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
 
About Insiderslab.com:
 
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
 
Important Disclaimer:
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
Source:
www.insiderslab.com
www.insiderslab.com

Reported on Nov 11, 2013

 
More Insider News ...

Today's Notable Trades


NovaBay Pharmaceuticals, Inc. (NBY)
Director: SIECZKAREK MARK M

Acquired 166,666 Common Stock (Non-Derivative security at $0.600) on Mar 3, 2015. Direct holding 196,466 shares/units after transaction. Holdings increased 559.28%.
Filing date: Mar 5, 2015. Record updated at 22:21:56.
 
Oasis Petroleum Inc. (OAS)
10% shareholder: SPO ADVISORY CORP

Acquired 8,000,000 Common Stock (Non-Derivative security at $12.800) on Mar 4, 2015. Indirect holding 20,374,500 shares/units after transaction. Holdings increased 64.65%.
Filing date: Mar 4, 2015. Record updated at 22:20:42.
 
Alkermes plc. (ALKS)
Senior Officer (SVP, COO & CRO, Alkermes, Inc.): Pugh Gordon G

Sold 1,531 Ordinary Shares (Non-Derivative security at $72.800) on Mar 3, 2015. Direct holding 8,358 shares/units after transaction. Holdings decreased -15.48%.
Filing date: Mar 5, 2015. Record updated at 22:19:57.
 
VAALCO ENERGY INC /DE/ (EGY)
Director: Chapoton O Don

Acquired 60,000 Common Stock (Non-Derivative security at $4.280) on Mar 3, 2015. Direct holding 87,900 shares/units after transaction. Holdings increased 215.05%.
Filing date: Mar 5, 2015. Record updated at 22:19:47.
 
VOCERA COMMUNICATIONS, INC. (VCRA)
Director: Nada Hany

Sold 1,588 Common Stock (Non-Derivative security at $10.790) on Mar 3, 2015. Indirect holding 9,698 shares/units after transaction. Holdings decreased -14.07%.
Filing date: Mar 5, 2015. Record updated at 22:19:44.
 
NEWPORT CORP (NEWP)
Director: SIMONE PETER J

Acquired 7,500 Common Stock (Non-Derivative security at $13.860) on Mar 3, 2015. Direct holding 47,278 shares/units after transaction. Holdings increased 18.85%.
Filing date: Mar 5, 2015. Record updated at 22:19:34.
 
GlyEco, Inc. (GLYE)
Senior Officer (Chief Financial Officer): Williams Alicia

Acquired 26,667 Restricted Common Stock (Non-Derivative security at $0.300) on Feb 28, 2015. Direct holding 226,707 shares/units after transaction. Holdings increased 13.33%.
Filing date: Mar 5, 2015. Record updated at 22:18:52.
 
KYTHERA BIOPHARMACEUTICALS INC (KYTH)
Senior Officer (Chief Financial Officer): Smither John W

Sold 2,000 Common Stock (Non-Derivative security at $46.990) on Mar 5, 2015. Indirect holding 14,416 shares/units after transaction. Holdings decreased -12.18%.
Filing date: Mar 5, 2015. Record updated at 22:18:16.
 
Leidos Holdings, Inc. (LDOS)
Director: HAMRE JOHN J

Acquired 3,728 Common Stock (Non-Derivative security at $44.784) on Mar 3, 2015. Direct holding 7,520 shares/units after transaction. Holdings increased 98.31%.
Filing date: Mar 5, 2015. Record updated at 22:18:00.
 
KOHLS Corp (KSS)
First-Class Insider (Chairman, President, CEO): MANSELL KEVIN

Acquired 50,000 Common Stock (Non-Derivative security at $42.890) on Mar 3, 2015. Direct holding 359,578 shares/units after transaction. Holdings increased 16.15%.
Filing date: Mar 5, 2015. Record updated at 22:17:29.
 
Read more

Disclaimer

InsidersLab.com focuses on tracking and monitoring insider trading activities in the US stocks market. "Insider Trading" means trading activities created by company directors, senior officers, individual substantial shareholders, and institutional shareholders. InsidersLab.com does not represent, warrant, nor endorse the accuracy, reliability, completeness or timeliness of any of the information, content, views, opinions, recommendations or advertisements (collectively, the "Materials") contained on, distributed through, or linked, downloaded or accessed from any of the services contained on the website (the "Service"), nor the quality of any products, information or other materials displayed, purchased, or obtained by you as a result of an advertisement or any other information or offer in or in connection with the Service (the "Products"). InsidersLab.com collects insider trading information from different public sources such as newspapers, financial information websites, and government statistics publications. You hereby acknowledge that any reliance upon any Materials shall be at your sole risk. In particular, none of the Materials is provided on the InsidersLab.com website or emails with a view to inviting, inducing or encouraging any person to make any kind of investment decision. Securities or other investments referred to in the Materials may not be suitable for you and you should not make any kind of investment decision in relation to them without first obtaining independent investment advice from a person authorized to give it.